Health Catalyst

We’re just days out from #HFMA2026, but there’s still time to register for our reception. If you’ll be in National Harbor next week, join Health Catalyst and The Wilshire Group for an evening with a smaller group of healthcare finance and executive leaders. Bar Harbor sets the scene with waterfront views, delicious bites, and an evening of connection and conversation. June 8th | 7–9 PM | Bar Harbor, National Harbor, MD Space is limited — save your spot: https://luma.com/nzuadje6

We’re just days out from #HFMA2026, but there’s still time to register for our reception. If you’ll be in National Harbor next week, join Health Catalyst and The Wilshire Group for an evening with a smaller group of healthcare finance and executive leaders. Bar Harbor sets the scene with waterfront views, delicious bites, and an evening of connection and conversation. June 8th | 7–9 PM | Bar Harbor, National Harbor, MD Space is limited — save your spot: https://luma.com/nzuadje6

Conversations with leaders who are working through the exact problems we spend our days solving are the ones that energize us most. We're excited to attend #HFMA2026 — where we're hosting a reception with The Wilshire Group to create space for that dialogue in a smaller, more intentional setting. Join us for food, drinks, and a chance to keep the momentum going after the agenda ends. June 8th | 7:00–9:00 PM | Bar Harbor in National Harbor, MD Space is limited. Save your spot: https://luma.com/nzuadje6

We're heading to #ASCO2026 with something worth bringing: five years of real-world evidence on what electronic patient-reported outcomes (ePRO) data reveals about acute myeloid leukemia (AML) patients that clinical data alone might miss. Our recent research makes a case we've been exploring directly with clients: frailty and functional status are meaningfully under-characterized in real-world AML treatment decisions. Across treatment groups — intensive vs. less intensive — ePROs revealed clinically significant differences in symptom burden that molecular and clinical data didn't surface. Biomarker risk stratification aligns with treatment intensity selection, but it's an incomplete picture without understanding how patients are actually functioning and feeling. That's what patient-reported data does. And when it's collected at scale through purpose-built tech, it generates evidence that moves the field beyond individual care plans. This work was powered by Carevive, and we're proud to be presenting it alongside some of the sharpest minds in oncology this week in Chicago. Come find us if you’re there — we’d welcome the conversation. Preview the abstract here: https://lnkd.in/guSdU-nc

At #ISPOR 2026, we're sharing what ePRO data is teaching us about oncology care, and the picture that emerges when you listen to patients at scale. Machine learning on real-world ePRO data surfaced a group of highest-risk patients. And they weren't who we expected. They were younger, frailer, more socially isolated. We also found that their distance from the cancer center and absence of a caregiver meaningfully amplifies risk, and these factors are easily missed by conventional risk models. In collaboration with UCLA, we also confirmed that navigator-facilitated ePROs are feasible in pancreatic cancer, one of oncology's most acute and complex populations. They surface symptom burden and nutritional risk that structured screenings often fail to uncover. And patients feel heard in the process. Together, these findings point to something we believe strongly: ePRO data, deployed at scale and supported by clinicians and navigators, is teaching the field things claims data and traditional outcome measures can't— because it captures what patients are actually experiencing. If you're at ISPOR, come find us. We'd love to go deeper on the findings and how to apply them.

Today we welcomed Steve Nelson to our Board of Directors. As President of Aetna, a CVS Health Company, former CEO of UnitedHealthcare, and former CEO of ChenMed, Steve has led across nearly every part of the #healthcare ecosystem. He understands deeply what health systems are up against, and what it takes to address those challenges. Steve's appointment reflects a continued focus on building the leadership and AI-enabled technology our clients need to address the challenges they face every day: controlling costs, improving clinical quality, and elevating the consumer and provider experience. This is the work we are committed to, and we are grateful to have Steve at the table. View full press release: https://lnkd.in/ghfTT3UG

The day is underway here at the NAACOS Spring Conference in Baltimore! Be sure to visit us at Booth P during the conference to learn how teams are moving beyond static reporting and turning performance insight into targeted action that drives measurable value-based care results. Christopher Bergmann Miriah Dahlquist Travis Simar

The LONL Spring Conference 2026 is underway! Set up time to meet with a Health Catalyst expert. We will walk through how you can connect workforce strategy, quality, and financial performance, and identify where to focus for measurable impact. Book time with our team and make your conference time count - https://bit.ly/4mtX7q6 Cathy Menkiena, MBA, FACHE, NI-BC, FHIMSS, FACHDM Jacqueline Matthews, RN, MS

Know where to act in your ACO. Value-based care teams are working hard. Many still struggle to pinpoint which actions will move quality scores and shared savings. At the NAACOS Spring in Baltimore, connect with the Health Catalyst team at Booth P to learn how organizations are: • Moving beyond static reporting • Focusing improvement efforts where impact is highest • Using leading indicators to guide performance strategy • Driving measurable results across value-based programs Make time to stop by Booth P and talk through the performance challenges you are working to solve this year.

Clinical quality improvement needs more than reports. It requires trusted data, clear priorities, and action teams can execute. See how leading health systems are using analytics to improve outcomes and drive measurable performance. https://bit.ly/42hqQcn